G
GIAA
vs
KNRS
G
GIAA
KNRS
Over the past 12 months, GIAA has significantly outperformed KNRS, delivering a return of +70% compared to the KNRS's 0% growth.
This Feature is Available on
Paid Plans
Paid Plans
This Feature is Available on Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
14-day money-back guarantee
Smart Verdict
AI-Powered
Not Sure Which Stock Wins?
Let AI Decide.
Let AI Decide.
GIAA
KNRS
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Summarizing...
We need a little more time to summarize the results
Valuation Comparison
G
GIAA
Intrinsic Value
63.47
IDR
Overvaluation 13%
KNRS
Intrinsic Value
Not Available
| Company | Last Price | Intrinsic Value | DCF Value | Multiples-Based Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
G
|
Garuda Indonesia (Persero) Tbk PT
IDX:GIAA
|
73
IDR
|
|||||
|
Kinarus Therapeutics Holding AG
SIX:KNRS
|
15
CHF
|
|||||
No Stocks Selected
Compare the stock's valuation with its competitors.
Valuation Scenario:
Growth Comparison
Growth Over Time
GIAA, KNRS
GIAA, KNRS
Revenue
www.alphaspread.com
No Stocks Selected
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
G
|
Garuda Indonesia (Persero) Tbk PT
Revenue
|
|||||||||||
|
|
Kinarus Therapeutics Holding AG
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
No Stocks Selected
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
GIAA, KNRS
GIAA, KNRS
Free Cash Flow
www.alphaspread.com
No Stocks Selected
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
G
|
Garuda Indonesia (Persero) Tbk PT
IDX:GIAA
|
|||||||||
|
|
Kinarus Therapeutics Holding AG
SIX:KNRS
|
|||||||||
No Stocks Selected
Compare company's free cash flow with its competitors.
Gross Margin
GIAA
17.7%
KNRS
0%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
G
|
Garuda Indonesia (Persero) Tbk PT | ||||
|
|
Kinarus Therapeutics Holding AG | ||||
Operating Margin
GIAA
3.5%
KNRS
0%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
G
|
Garuda Indonesia (Persero) Tbk PT | ||||
|
|
Kinarus Therapeutics Holding AG | ||||
Net Margin
GIAA
-10%
KNRS
0%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
G
|
Garuda Indonesia (Persero) Tbk PT | ||||
|
|
Kinarus Therapeutics Holding AG | ||||
FCF Margin
GIAA
2.2%
KNRS
0%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
G
|
Garuda Indonesia (Persero) Tbk PT | ||||
|
|
Kinarus Therapeutics Holding AG | ||||
ROE
GIAA
49.2%
KNRS
-237.1%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
G
|
Garuda Indonesia (Persero) Tbk PT | ||||
|
|
Kinarus Therapeutics Holding AG | ||||
ROA
GIAA
-4.6%
KNRS
-219.8%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
G
|
Garuda Indonesia (Persero) Tbk PT | ||||
|
|
Kinarus Therapeutics Holding AG | ||||
ROIC
GIAA
1.6%
KNRS
-247.6%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
G
|
Garuda Indonesia (Persero) Tbk PT | ||||
|
|
Kinarus Therapeutics Holding AG | ||||
ROCE
GIAA
2%
KNRS
-237%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
G
|
Garuda Indonesia (Persero) Tbk PT | ||||
|
|
Kinarus Therapeutics Holding AG | ||||
Solvency Comparison
G
Garuda Indonesia (Persero) Tbk P...
Equity Waterfall
Assets
Liabilities
Equity
Kinarus Therapeutics Holding AG
Equity Waterfall
Assets
Liabilities
Equity
No Stocks Selected
Compare company's equity waterfall with its competitors.
Balance Sheet Comparison
Stocks Performance
Stocks Performance
GIAA, KNRS
GIAA, KNRS
Performance By Year
GIAA, KNRS
GIAA, KNRS
Loading
No Stocks Selected
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Compare GIAA to other stocks
GOLL4
Gol Linhas Aereas Inteligentes...
More expensive
vs GIAA
DAL
Delta Air Lines Inc
Cheaper
vs GIAA
UAL
United Airlines Holdings Inc
Cheaper
vs GIAA
IAG
International Consolidated Air...
Cheaper
vs GIAA
Select Stock to Compare
| BR |
|
Gol Linhas Aereas Inteligentes SA
BOVESPA:GOLL4
|
|
| US |
|
Delta Air Lines Inc
NYSE:DAL
|
|
| US |
|
United Airlines Holdings Inc
NASDAQ:UAL
|
|
| CH |
|
Kinarus Therapeutics Holding AG
SIX:KNRS
|
|
| UK |
|
International Consolidated Airlines Group SA
LSE:IAG
|
|
| US |
|
Southwest Airlines Co
NYSE:LUV
|
|
| IE |
R
|
Ryanair Holdings PLC
LSE:RYA
|
|
| IN |
|
Interglobe Aviation Ltd
NSE:INDIGO
|
|
| CN |
|
Air China Ltd
SSE:601111
|
|
| SG |
|
Singapore Airlines Ltd
SGX:C6L
|
Loading...
Unlock Full Access to Alpha Spread
Create Free Account
